Evidence map›Paper›PMID 31809267›Full record

ArticleAging2019

Sphingosine-1-phosphate promotes PDGF-dependent endothelial progenitor cell angiogenesis in human chondrosarcoma cells.

Chao-Qun Wang, Chih-Yang Lin, Yuan-Li Huang, Shih-Wei Wang, Yan Wang, Bi-Fei Huang, Yu-Wei Lai, Shun-Long Weng, Yi-Chin Fong, Chih-Hsin Tang and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 2 countries.

Chao-Qun WangDepartment of Pathology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.
Chih-Yang LinDepartment of Medicine, Mackay Medical College, New Taipei, Taiwan.
Yuan-Li HuangDepartment of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan.
Shih-Wei WangDepartment of Medicine, Mackay Medical College, New Taipei, Taiwan.
Yan WangDepartment of Medical Oncology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.
Bi-Fei HuangDepartment of Pathology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.
Yu-Wei LaiDivision of Urology, Taipei Hospital Renai Branch, Taipei, Taiwan.
Shun-Long WengDepartment of Obstetrics and Gynaecology, Hsinchu MacKay Memorial Hospital, Hsinchu, Taiwan.
Yi-Chin FongDepartment of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan.
Chih-Hsin TangDepartment of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan.
Zhong LvDepartment of General Surgery, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.
Dongyang People's Hospital · CNWenzhou Medical University · CNAsia University · TWChina Medical University · TWChina Medical University Hospital · TWKaohsiung Medical University · TWMackay Medical College · TWMackay Memorial Hospital · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The malignant bone tumors that are categorized as chondrosarcomas display a high potential for metastasis in late-stage disease. Higher-grade chondrosarcomas contain higher levels of expression of platelet-derived growth factor (PDGF) and its receptor. The phosphorylation of sphingosine by sphingosine kinase enzymes SphK1 and SphK2 generates sphingosine-1-phosphate (S1P), which inhibits human chondrosarcoma cell migration, while SphK1 overexpression suppresses lung metastasis of chondrosarcoma. We sought to determine whether S1P mediates levels of PDGF-A expression and angiogenesis in chondrosarcoma. Surprisingly, our investigations found that treatment of chondrosarcoma cells with S1P and transfecting them with SphK1 cDNA increased PDGF-A expression and induced angiogenesis of endothelial progenitor cells (EPCs). Ras, Raf, MEK, ERK and AP-1 inhibitors and their small interfering RNAs (siRNAs) inhibited S1P-induced PDGF-A expression and EPC angiogenesis. Our results indicate that S1P promotes the expression of PDGF-A in chondrosarcoma via the Ras/Raf/MEK/ERK/AP-1 signaling cascade and stimulates EPC angiogenesis.

Indexed as

Cell Line, TumorChondrosarcomaExtracellular Signal-Regulated MAP KinasesGene Expression Regulation, NeoplasticHumansLysophospholipidsMAP Kinase Kinase 1Neovascularization, PathologicPlatelet-Derived Growth Factorraf Kinasesras ProteinsSphingosineTranscription Factor AP-1Extracellular Signal-Regulated MAP KinasesLysophospholipidsMAP Kinase Kinase 1Platelet-Derived Growth Factorplatelet-derived growth factor Araf Kinasesras ProteinsSphingosinesphingosine 1-phosphateTranscription Factor AP-1angiogenesischondrosarcomaEPCsPDGF-AS1P

Identifiers

PMID31809267
PMCPMC6932882
OpenAlexW2991763858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.